H30.109
Unspecified disseminated chorioretinal inflammation, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified disseminated chorioretinal inflammation refers to a condition where inflammation affects the choroid and retina layers of the eye, leading to widespread or diffuse inflammation across parts of the eye without a specific localized area. This condition can impact vision and eye health, but its exact cause often remains unclear, making diagnosis and management challenging. It falls under the ICD-10 code H30.109, indicating an unspecified form of this inflammatory process in the eye.
Causes & Symptoms
Clinical Causes: Autoimmune responses, where the immune system mistakenly attacks eye tissues Infections, such as viral, bacterial, or parasitic agents Inflammatory or systemic diseases like sarcoidosis or tuberculosis Unknown or idiopathic factors, where no specific cause is identified Complications from other eye conditions or injuries Reaction to certain medications or toxins
Key Symptoms: Blurred or decreased vision Floaters or spots in the vision Eye redness and swelling Light sensitivity (photophobia) Eye pain or discomfort Possible loss of peripheral or central vision if inflammation persists
Diagnostic & Treatment
Diagnosis Path: Diagnosing unspecified disseminated chorioretinal inflammation involves a comprehensive eye examination, including visual acuity testing, slit-lamp examination, and fundus examination to visualize the retina and choroid. Additional diagnostic tools may include optical coherence tomography (OCT), fluorescein angiography, or indocyanine green angiography, which help assess the extent of inflammation and involvement of eye structures. A thorough medical history and physical examination may also be conducted to identify underlying causes, systemic diseases, or infections.
Treatment Protocols: Treatment options typically focus on reducing inflammation and managing symptoms. These may include corticosteroids (such as eye drops, oral medications, or injections) to decrease inflammation. Immunosuppressive drugs might be prescribed if an autoimmune component is suspected. Addressing any underlying infections with appropriate antimicrobial agents is also crucial. Regular monitoring by an eye care specialist is essential to assess response to treatment and prevent potential complications such as scarring or permanent vision loss. In some cases, supportive measures like vision aids or frequent eye check-ups are recommended to preserve eye health and function.
Clinical Advice & FAQs
Billing Guidance
Is H30.109 a billable ICD-10 code?
Yes, H30.109 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H30.109?
Clinical documentation must specify the nature of Unspecified disseminated chorioretinal inflammation, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference